These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32771461)

  • 41. [Current inpatient treatment options for COVID-19: an update].
    Hensgens MPM; Gieling E; de Lange D; Boersma WG; van der Linden P; Sinha BNM; de Boer M
    Ned Tijdschr Geneeskd; 2022 Jul; 166():. PubMed ID: 36036698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic agents in patients with COVID-19.
    Khan F; Tritschler T; Zarychanski R
    CMAJ; 2022 May; 194(20):E704. PubMed ID: 35609908
    [No Abstract]   [Full Text] [Related]  

  • 43. Unproven Therapy Algorithms for Early SARS-CoV-2 Infection Are Dangerous.
    Olmos RD; Roque FL
    Am J Med; 2021 May; 134(5):e345. PubMed ID: 33962709
    [No Abstract]   [Full Text] [Related]  

  • 44. Early use of fondaparinux at therapeutic dosage in COVID-19 infection.
    Borghi B; Borghi R; DE Amicis T; Sommariva C; Pipino G
    Minerva Anestesiol; 2021 Aug; 87(8):958-960. PubMed ID: 33960182
    [No Abstract]   [Full Text] [Related]  

  • 45. Summary for Patients: Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1).
    Ann Intern Med; 2023 Jan; 176(1):I26. PubMed ID: 36442069
    [No Abstract]   [Full Text] [Related]  

  • 46. Outpatient Treatment of Confirmed COVID-19.
    Sullivan DJ; Franchini M; Senefeld JW; Joyner MJ; Casadevall A; Focosi D
    Ann Intern Med; 2023 May; 176(5):eL230099. PubMed ID: 37068278
    [No Abstract]   [Full Text] [Related]  

  • 47. Summary for Patients: Outpatient Treatment of Confirmed COVID-19.
    Ann Intern Med; 2023 Jan; 176(1):I24. PubMed ID: 36442068
    [No Abstract]   [Full Text] [Related]  

  • 48. Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections.
    Otto CM
    Heart; 2022 Jan; 108(2):83-85. PubMed ID: 34937799
    [No Abstract]   [Full Text] [Related]  

  • 49. Response to: Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19.
    Bonilla CRG
    Arch Med Res; 2022 Jul; 53(5):541-542. PubMed ID: 35752533
    [No Abstract]   [Full Text] [Related]  

  • 50. Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19.
    León-Rosales SP; García LG; Zamboni DR; Doherty PS; Rodríguez-Álvarez M
    Arch Med Res; 2022 Jul; 53(5):539-540. PubMed ID: 35595593
    [No Abstract]   [Full Text] [Related]  

  • 51. Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives.
    Schulman S; Harenberg J
    Thromb Haemost; 2021 Jul; 121(7):849-853. PubMed ID: 33831961
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunotherapy in COVID-19: why, who, and when?
    Sinha P; Calfee CS
    Lancet Respir Med; 2021 Jun; 9(6):549-551. PubMed ID: 34015326
    [No Abstract]   [Full Text] [Related]  

  • 53. [Not Available].
    Nilius G
    MMW Fortschr Med; 2022 Jan; 164(1):24-26. PubMed ID: 35043319
    [No Abstract]   [Full Text] [Related]  

  • 54. Analysis of an ambulatory care pathway for patients with COVID-19 utilising remote pulse oximetry.
    Kyriakides J; Khani A; Kelly C; Coleman R
    Clin Med (Lond); 2021 Mar; 21(Suppl 2):48-49. PubMed ID: 34078698
    [No Abstract]   [Full Text] [Related]  

  • 55. Never Give Up: Lesson learned from a severe COVID-19 patient.
    Tonelli R; Iattoni A; Girardis M; De Pietri L; Clini E; Mussini C;
    Pulmonology; 2021; 27(3):257-260. PubMed ID: 32362506
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hypromellose derivatives for preventing SARS-CoV-2 infection: a systematic review].
    Hernández-Vásquez A; Azañedo D; Vargas-Fernández R; Comandé D
    Rev Peru Med Exp Salud Publica; 2021; 38(3):469-471. PubMed ID: 34932751
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-19-Lessons Learned and Questions Remaining.
    Fang FC; Benson CA; Del Rio C; Edwards KM; Fowler VG; Fredricks DN; Limaye AP; Murray BE; Naggie S; Pappas PG; Patel R; Paterson DL; Pegues DA; Petri WA; Schooley RT
    Clin Infect Dis; 2021 Jun; 72(12):2225-2240. PubMed ID: 33104186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of COVID-19 on the Quadruple Aim.
    Stefanacci RG
    Popul Health Manag; 2021 Oct; 24(5):540-542. PubMed ID: 33155873
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19: The therapeutic landscape.
    Paules CI; Fauci AS
    Med; 2021 May; 2(5):493-497. PubMed ID: 33899041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The increased hemoglobin oxygen affinity in COVID-19.
    Vogel DJ; Formenti F; Camporota L
    Am J Physiol Lung Cell Mol Physiol; 2021 Sep; 321(3):L637. PubMed ID: 34491859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.